Found a Thyroid Nodule? How Doctors Decide If It Needs a Biopsy

Discovering a thyroid nodule can be unsettling, but it's very common. Up to 50% of people over age 60 have nodules detectable by ultrasound. Most are benign, and the overall thyroid nodule cancer risk is low—about 5–15%. Here's how doctors evaluate nodules and decide when a biopsy is needed.

---

What Is a Thyroid Nodule?

A thyroid nodule is a discrete lump within the thyroid gland in the neck.
• Often found on routine exam or imaging for another reason
• Usually painless and slow-growing
• Can be solid, cystic (fluid-filled), or mixed

---

Initial Evaluation

1. Medical History & Physical Exam
   • Family history of thyroid cancer
   • Prior radiation exposure (especially in childhood)
   • Rapid growth, difficulty swallowing or breathing, voice changes
2. Laboratory Tests
   • TSH (thyroid-stimulating hormone): low TSH may suggest a "hot" (functioning) nodule
   • Free T4, T3 if TSH is abnormal

---

Ultrasound: The Cornerstone of Risk Assessment

Thyroid ultrasound characterizes nodules by size and appearance. Features linked to higher thyroid nodule cancer risk include:

• Hypoechoic texture (darker than surrounding tissue)
• Irregular or microlobulated margins
• Microcalcifications (tiny calcium spots)
• Taller-than-wide shape on transverse view
• Increased internal blood flow

TI-RADS Scoring

Radiologists often use the Thyroid Imaging Reporting and Data System (TI-RADS) to stratify cancer risk:

Category	Features	Approximate Cancer Risk	Biopsy Recommendation
TR1	Normal thyroid	~0%	No biopsy
TR2	Benign features	<2%	No biopsy
TR3	Mild suspicion	2–5%	Biopsy if ≥2.5 cm; follow if 1.5–2.4 cm
TR4	Moderate suspicion	5–20%	Biopsy if ≥1.5 cm; follow if 1–1.4 cm
TR5	High suspicion	>20%	Biopsy if ≥1.0 cm; follow if 0.8–0.9 cm

---

Deciding on Fine-Needle Aspiration (FNA)

Fine-needle aspiration biopsy (FNA) is the standard test for suspicious nodules:

• Indications for FNA

• Nodules ≥1 cm with high-risk ultrasound features
• Nodules ≥1.5–2 cm with low-risk features
• Any size if clinical risk factors present (e.g., family history, radiation)

• When to Observe Instead of Biopsying

• TI-RADS 2 or pure cysts (no biopsy)
• Small (<1 cm) low-suspicion nodules—regular ultrasound follow-up

---

Interpreting FNA Results: The Bethesda System

FNA cytology is reported using the Bethesda System, which guides next steps:

1. Bethesda I (Non-diagnostic)
   • Repeat FNA
2. Bethesda II (Benign)
   • Cancer risk ~0–3%
   • Ultrasound follow-up in 12–24 months
3. Bethesda III (Atypia of Undetermined Significance)
   • Cancer risk ~5–15%
   • Repeat FNA or molecular testing
4. Bethesda IV (Follicular Neoplasm)
   • Cancer risk ~15–30%
   • Consider surgery or molecular testing
5. Bethesda V (Suspicious for Malignancy)
   • Cancer risk ~60–75%
   • Surgical removal usually recommended
6. Bethesda VI (Malignant)
   • Cancer risk ~97–99%
   • Surgery and cancer management

Molecular testing on FNA samples can refine risk estimates, especially for Bethesda III/IV.

---

Clinical Risk Factors

Doctors weigh ultrasound and cytology against personal risk factors:

• Radiation Exposure

• Especially head/neck radiation in childhood
  • Family History
• First-degree relatives with thyroid cancer
  • Age & Gender
• Under 20 or over 70 at slightly higher risk
• Slight female predominance, but male nodules more often malignant
  • Rapid Growth or Symptoms
• Quick nodule enlargement, pain, voice changes, or trouble swallowing

If these factors are present, a lower threshold for biopsy or surgery may apply.

---

Hot vs. Cold Nodules

If TSH is low, a radionuclide (thyroid) scan helps:

• Hot (Functioning) Nodules

• Take up more tracer, usually benign
• Rarely biopsied unless suspicious features exist
  • Cold (Non-functioning) Nodules
• Most common type
• Evaluated by ultrasound and FNA if indicated

---

Surveillance and Follow-Up

For nodules not requiring immediate biopsy or surgery:

• Ultrasound Monitoring

• First follow-up at 6–12 months
• Then every 1–2 years if stable
  • Growth Thresholds
• ≥20% increase in at least two dimensions (with minimum 2 mm increase) may prompt biopsy
  • Symptoms or Lab Changes
• New compression symptoms or TSH changes warrant re-evaluation

---

Reducing Anxiety While Staying Informed

Learning about your thyroid nodule can be stressful. Keep in mind:

• Most nodules are benign.
• Early evaluation and structured guidelines help catch cancer early.
• Your healthcare team tailors decisions based on your individual risk.

If you're experiencing neck discomfort, swallowing issues, or other symptoms related to your thyroid, our free AI symptom checker can help you understand your symptoms and determine whether you should schedule a doctor's appointment soon.

---

Key Takeaways

• Thyroid nodules are common; cancer risk is low (5–15%).
• Ultrasound features and size guide biopsy decisions (TI-RADS scores).
• FNA results (Bethesda categories) determine management steps.
• Clinical factors (radiation, family history, rapid growth) influence risk.
• Most nodules don't need immediate biopsy—regular ultrasound follow-up is safe.
• Always report new symptoms like voice changes, swallowing issues, or rapid growth.

---

When to Speak to a Doctor

If you have any concerning symptoms—pain, difficulty breathing or swallowing, voice changes—or if you're worried about your thyroid nodule, speak to a doctor. They can perform the appropriate exams, labs, and imaging to guide you toward the best care plan. If you ever feel symptoms could be life-threatening or serious, seek medical attention promptly.